You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute Lymphoblastic Leukemia (ALL) Philadelphia chromosome positive

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

Recruiting
  • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 13, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

Not yet recruiting
  • Philadelphia-Positive ALL
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Soochow University
Jul 1, 2023

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • (no location specified)
Dec 28, 2020

Blasts 5 Percent or More of Bone Marrow Nucleated Cells, CD22 Positive, Philadelphia Chromosome Positive Trial in Monrovia,

Recruiting
  • Blasts 5 Percent or More of Bone Marrow Nucleated Cells
  • +4 more
  • ADCT-602
  • Monrovia, California
  • +1 more
Dec 7, 2022

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
Has Results
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Duarte, California
  • +21 more
Sep 8, 2022

Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib combined with chemo)

Not yet recruiting
  • Philadelphia-Positive ALL
  • Olverembatinib combined with chemotherapy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Jul 17, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Completed
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
    • Limerick, Dooradoyle, Ireland
    • +32 more
    Aug 13, 2021

    Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • inotuzumab ozogamicin
    • (no location specified)
    Jan 6, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • HY004
    • +2 more
    • (no location specified)
    Aug 18, 2023

    B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
    • Bone Marrow Aspiration and Biopsy
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 11, 2022

    Acute Lymphoblastic Leukemia Trial (GRASPA)

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • (no location specified)
    Sep 21, 2021

    Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

    Recruiting
    • Lymphoblastic Leukemia
    • +2 more
    • Inotuzumab ozogamicin
    • +7 more
    • Chicago, Illinois
      University of Chicago Medical Center
    May 16, 2022

    Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

    Recruiting
    • Lymphoblastic Lymphoma
    • +2 more
    • BEAM-201
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 2, 2023

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • +2 more
    • Ponatinib 15 MG Oral Tablet
    • Brno, Czechia
    • +6 more
    Nov 30, 2022

    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Acute Lymphoblastic Leukemia
    • Bordeaux, Aquitaine, France
    • +11 more
    Dec 6, 2020

    Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

    Not yet recruiting
    • Pediatric Acute Lymphoblastic Leukemia
    • +2 more
    • Sleep ALL Night
    • Boston, Massachusetts
    • +1 more
    May 10, 2023

    Acute Lymphoblastic Leukemia, Adult Trial in Caba (Evaluation of survival and toxicities in AYA Ph-negative ALL patients

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.
    • Paraná, Entre Ríos, Argentina
    • +1 more
    Dec 29, 2022